Mullein side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Abdominal pain upper
2. Anxiety
3. Application site pruritus (application site severe itching of the skin)
4. Arthralgia (joint pain)
5. Back pain
6. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
7. Concussion (short loss of normal brain function in response to a head injury)
8. Disease progression
9. Drug ineffective
10. Dry eye (lack of adequate tears)

male:

1. Acute hepatic failure
2. Chest pain
3. Haemorrhage intracranial (bleeding within the skull)
4. Blood glucose increased
5. Constipation
6. Decreased activity
7. Hepatic failure (liver failure)

0-1:

n/a

2-9:

1. Feeling abnormal

10-19:

n/a

20-29:

n/a

30-39:

1. Anxiety

40-49:

1. Urinary incontinence (inability to control the flow of urine and involuntary urination)

50-59:

1. Abdominal discomfort
2. Disease progression
3. Dry eye (lack of adequate tears)

60+:

1. Abdominal distension
2. Abdominal pain upper
3. Application site pruritus (application site severe itching of the skin)
4. Arthralgia (joint pain)
5. Back pain
6. Blood glucose increased
7. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
8. Concussion (short loss of normal brain function in response to a head injury)
9. Constipation
10. Chest pain